| Company/Division name | Orchard Therapeutics |
| Parent company | Orchard Therapeutics |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2018 |
| Year reshoring implemented or to be implemented: | 2019 |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Fremont |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, Biopharmaceuticals |
| Product(s) reshored | gene therapy products |
| What domestic positive factors made reshoring more attractive? | Customization/Flexibility, Higher productivity |
